JP2022541502A5 - - Google Patents

Info

Publication number
JP2022541502A5
JP2022541502A5 JP2022502832A JP2022502832A JP2022541502A5 JP 2022541502 A5 JP2022541502 A5 JP 2022541502A5 JP 2022502832 A JP2022502832 A JP 2022502832A JP 2022502832 A JP2022502832 A JP 2022502832A JP 2022541502 A5 JP2022541502 A5 JP 2022541502A5
Authority
JP
Japan
Prior art keywords
hla
cells
preparation
expression
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022502832A
Other languages
English (en)
Japanese (ja)
Other versions
JP7708737B2 (ja
JP2022541502A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042768 external-priority patent/WO2021011936A2/en
Publication of JP2022541502A publication Critical patent/JP2022541502A/ja
Publication of JP2022541502A5 publication Critical patent/JP2022541502A5/ja
Application granted granted Critical
Publication of JP7708737B2 publication Critical patent/JP7708737B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022502832A 2019-07-18 2020-07-20 細胞の細胞型選択的免疫保護 Active JP7708737B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962875883P 2019-07-18 2019-07-18
US62/875,883 2019-07-18
PCT/US2020/042768 WO2021011936A2 (en) 2019-07-18 2020-07-20 Cell-type selective immunoprotection of cells

Publications (3)

Publication Number Publication Date
JP2022541502A JP2022541502A (ja) 2022-09-26
JP2022541502A5 true JP2022541502A5 (https=) 2023-07-06
JP7708737B2 JP7708737B2 (ja) 2025-07-15

Family

ID=71995146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502832A Active JP7708737B2 (ja) 2019-07-18 2020-07-20 細胞の細胞型選択的免疫保護

Country Status (6)

Country Link
US (1) US20220267737A1 (https=)
EP (1) EP3999627A2 (https=)
JP (1) JP7708737B2 (https=)
CN (1) CN114787358B (https=)
CA (1) CA3144687A1 (https=)
WO (1) WO2021011936A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6541577B2 (ja) 2013-02-06 2019-07-10 ユニバーシティー オブ ロチェスター ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞
US9724432B2 (en) 2015-04-30 2017-08-08 University Of Rochester Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
WO2023150553A1 (en) * 2022-02-01 2023-08-10 University Of Rochester Gpr17 promoter-based targeting and transduction of glial progenitor cells
US11690876B2 (en) 2017-05-10 2023-07-04 University Of Rochester Methods of treating neuropsychiatric disorders
CA3103675A1 (en) 2018-06-21 2019-12-26 University Of Rochester Methods of treating or inhibiting onset of huntington's disease
KR20220158046A (ko) 2020-03-25 2022-11-29 사나 바이오테크놀로지, 인크. 신경계 장애 및 병태의 치료를 위한 면역저하성 신경 세포
US11459372B2 (en) 2020-11-30 2022-10-04 Crispr Therapeutics Ag Gene-edited natural killer cells
WO2022144632A1 (en) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into nk cells
EP4649150A1 (en) * 2023-01-13 2025-11-19 Laverock Therapeutics Limited Cell context-specific gene regulation using inhibitory rnas
WO2025222093A2 (en) * 2024-04-19 2025-10-23 Factor Bioscience Inc. Engineered cells and uses thereof
WO2025250531A1 (en) * 2024-05-28 2025-12-04 Thymmune Therapeutics, Inc. Hypoimmune engineering for universal ipsc-derived cells

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080119427A1 (en) 1996-06-06 2008-05-22 Isis Pharmaceuticals, Inc. Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US6794499B2 (en) 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
US6812027B2 (en) 1998-03-25 2004-11-02 Cornell Research Foundation, Inc. Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain
US6838283B2 (en) 1998-09-29 2005-01-04 Isis Pharmaceuticals Inc. Antisense modulation of survivin expression
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
ES2234563T5 (es) 1999-02-12 2018-01-17 Daiichi Sankyo Company, Limited Nuevos análogos de nucleósidos y oligonucleótidos
US7098192B2 (en) 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
US7468277B2 (en) 1999-12-23 2008-12-23 Cornell Research Foundation, Inc. Enriched preparation of human fetal multipotential neural stem cells
US7179796B2 (en) 2000-01-18 2007-02-20 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
US7785882B2 (en) 2000-01-18 2010-08-31 Cornell Research Foundation, Inc. Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them
WO2003070918A2 (en) 2002-02-20 2003-08-28 Ribozyme Pharmaceuticals, Incorporated Rna interference by modified short interfering nucleic acid
AU2002327433A1 (en) 2001-08-10 2003-02-24 Cornell Research Foundation, Inc. Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
WO2003087341A2 (en) 2002-01-23 2003-10-23 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
WO2003070171A2 (en) 2002-02-15 2003-08-28 Cornell Research Foundation, Inc. Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
DE60310944T3 (de) 2002-08-05 2017-08-03 Silence Therapeutics Gmbh Weitere neue formen von interferierende rns moleküle
US8642332B2 (en) 2003-03-07 2014-02-04 Cornell Research Foundation, Inc. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain
US8263406B2 (en) 2003-06-11 2012-09-11 Cornell Research Foundation, Inc. Enriched or purified population of motor neurons and its preparation from a population of embryonic stem cells
EP2256201A3 (en) 2003-09-18 2012-07-04 Isis Pharmaceuticals, Inc. Modulation of eIF4E expression
EP1684706A4 (en) 2003-11-10 2008-01-09 Cornell Res Foundation Inc GENES DIFFERENTIALLY EXPRESSED BY INSULATED PRECURSOR CELLS OF HUMAN WHITE MATTER
BRPI0716427A2 (pt) 2006-08-11 2014-03-11 Dow Agrosciences Llc Recombinação homóloga mediada por nuclease de apêndice de zinco
WO2009015294A1 (en) 2007-07-24 2009-01-29 Wisconsin Alumni Research Foundation Biomarkers for human papillomavirus-associated cancers
KR20100080068A (ko) 2008-12-31 2010-07-08 주식회사 툴젠 신규한 징크 핑거 뉴클레아제 및 이의 용도
US8586526B2 (en) 2010-05-17 2013-11-19 Sangamo Biosciences, Inc. DNA-binding proteins and uses thereof
HK1200871A1 (en) 2011-11-16 2015-08-14 Sangamo Therapeutics, Inc. Modified dna-binding proteins and uses thereof
JP6541577B2 (ja) 2013-02-06 2019-07-10 ユニバーシティー オブ ロチェスター ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞
WO2014134412A1 (en) 2013-03-01 2014-09-04 Regents Of The University Of Minnesota Talen-based gene correction
EP3004339B1 (en) 2013-05-29 2021-07-07 Cellectis New compact scaffold of cas9 in the type ii crispr system
WO2014197748A2 (en) 2013-06-05 2014-12-11 Duke University Rna-guided gene editing and gene regulation
BR112015031639A2 (pt) * 2013-06-19 2019-09-03 Sigma Aldrich Co Llc integração alvo
WO2015065964A1 (en) 2013-10-28 2015-05-07 The Broad Institute Inc. Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
WO2015089364A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Crystal structure of a crispr-cas system, and uses thereof
WO2015188056A1 (en) 2014-06-05 2015-12-10 Sangamo Biosciences, Inc. Methods and compositions for nuclease design
JP6598860B2 (ja) 2014-08-06 2019-10-30 カレッジ オブ メディシン ポチョン チャ ユニバーシティ インダストリー−アカデミック コーオペレイション ファウンデーション Ｈｌａをコードする遺伝子のヌクレアーゼ媒介編集により作製される免疫適合性細胞
CN107921148A (zh) * 2015-05-08 2018-04-17 哈佛学院校长同事会 通用供体干细胞和相关方法
CA2986310A1 (en) 2015-05-11 2016-11-17 Editas Medicine, Inc. Optimized crispr/cas9 systems and methods for gene editing in stem cells

Similar Documents

Publication Publication Date Title
JP2022541502A5 (https=)
JP7581183B2 (ja) ユニバーサルドナー細胞
JP6433480B2 (ja) Ｈｌａを修飾するための方法および組成物
JP2021106611A (ja) ヌクレアーゼ介在性遺伝子発現調節
US11433103B2 (en) Universal donor cells
Carvalho et al. Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
US11118195B2 (en) Universal donor cells
JP2022547053A5 (https=)
CN114026225A (zh) 安全的免疫隐形细胞
JP2024532772A5 (https=)
JP2024503291A (ja) ユニバーサルドナー細胞
JP2022547505A5 (https=)
WO2017197141A2 (en) Targeted treatment of androgenic alopecia
JP2025527629A (ja) 治療用細胞
Santore et al. Prenatal stem cell transplantation and gene therapy
WO2021172583A1 (ja) 遺伝子改変巨核球、改変血小板及びそれらの製造方法
CN101100666B (zh) 人TCRVβ7.1_H3F7基因及其筛选方法和应用
KR20260032524A (ko) 저면역원성의 범용성 유도만능줄기세포
WO2024008979A1 (en) A sirp-alpha binding chimeric protein
EP4638709A2 (en) Nk cell activating receptor ligand knockouts for use in cell therapy